Zurueck zur Suche

Reporte zur Charge U031359

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MD 2 TX 2 NH 2 ME 1 NY 1 IL 1 AZ 1 PA 1 DC 1 MA 1 FL 1 AR 1

VAERS 2319068

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

moderat
Staat
ME
Alter
58,0
Geschlecht
F
Eingang
14.06.2022
Impfdatum
10.06.2022
Beginn
10.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Nausea Rash Tachycardia Urticaria

Symptomtext

Dizziness, nausea, tachycardia, general hives/rash. Onset 2 hours post vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tachycardia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
Cataract, Glaucoma, Fibromyalgia
Andere Medikamente
-
Allergien
Penicillin
Vorherige Impfungen
Janssen COVID-19 vaccine, 4/3/2021, Age 57, Fibromyalgia flare up, arm pain

VAERS 2544835

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

mild
Staat
NY
Alter
38,0
Geschlecht
F
Eingang
28.12.2022
Impfdatum
30.11.2022
Beginn
30.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Immediate post-injection reaction Injection site erythema Injection site warmth Rash

Symptomtext

Within 1 minute of administration, pt noted with redness, heat to injection site (R arm). Pt was given PO liquids and 50 mg PO benadryl. She was monitored for 15 minutes, and was noted with rash to B/L LE and chest. Denies difficulty breathing. With assessment from provider, pt was escorted to ED triage at entrance with RN for further evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Denies
Vorgeschichte
Denies
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2512376

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

mild
Staat
IL
Alter
53,0
Geschlecht
F
Eingang
19.11.2022
Impfdatum
19.11.2022
Beginn
19.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Neck pain No adverse event Pain in extremity Product preparation issue Wrong product administered

Symptomtext

THE PATIENT WAS IN FOR A MMR VACCINE. I PULLED OUT THE DILUENT AND THE VACCINE. WHEN I RECONSTITUTED THE VACCINE I ACCIDENTALLY USED THE PFIZER BIVALENT INSTEAD OF THE DILUENT AND MIXED THEM TOGETHER. I THEN INJECTED THE PATIENT SUB-Q . WHEN I GOT BACK TO THE VACCINE TABLE I NOTICED THE DILUENT WAS STILL CAPPED. THEREFORE I MUST HAVE MIXED THE PFIZER BIVALENT WITH THE MMR VACCINE INSTEAD OF THE DILUENT. PATIENT COMPLAINS OF SORE ARM UP TO NECK AREA. NO OTHER ADVERSE EFFECTS SO FAR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Neck pain
Hospital-Tage
-
Labordaten
PATIENT IS GOING TO HOSPITAL TO BE CHECKED OUT
Aktuelle Erkrankungen
NONE
Vorgeschichte
none
Andere Medikamente
none
Allergien
nka
Vorherige Impfungen
-

VAERS 2490054

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

mild
Staat
AZ
Alter
17,0
Geschlecht
M
Eingang
26.10.2022
Impfdatum
25.10.2022
Beginn
25.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Rash

Symptomtext

Pt broke out In rash immediately after vaccination administered, he was given 25mg Benadryl on site. Pt was transferred out to Hospital to receive care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Allergies to mayonaise
Vorherige Impfungen
-

VAERS 2411512

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

mild
Staat
TX
Alter
5,0
Geschlecht
M
Eingang
15.08.2022
Impfdatum
15.08.2022
Beginn
15.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lip swelling Rash Swollen tongue

Symptomtext

Swelling to lips and tongue hive like rash to bilateral cheeks. reaction around 3:30 pm 5ml benadryl admin in office. EMS called and Patient transported to nearest ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2374909

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

mild
Staat
PA
Alter
1,0
Geschlecht
F
Eingang
20.07.2022
Impfdatum
19.07.2022
Beginn
20.07.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site rash Rash papular Urticaria

Symptomtext

Patient with a rash under the site of injection that is fine and papular and also noted on the opposite thigh and calf as well, some on the abdomen. The one on the calf is slightly urticarial. Advised them to give patient a bath as she was outdoors and to also give 6.25mg of Benadryl every 6 hours and if the rash fades would most likely be due to exposure to seasonal allergens by contact versus the vaccine. Mother to update me tomorrow.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2348500

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

mild
Staat
MD
Alter
1,0
Geschlecht
M
Eingang
01.07.2022
Impfdatum
28.06.2022
Beginn
29.06.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Urticaria

Symptomtext

mild urticarial rash noted face, trunk , extremities note the following day after vaccination. As of 7/1, rash comes and goes and disappears with Diphenhydramine. Child acting fine, no fever, eating, drinking and playing as normal

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Otitis media diagnosed 6/17/22, treated with Amoxicillin x 10 days. COVID vaccine given in combination with other 12 month vaccines: MMR, Varivax and Hepatitis A
Vorgeschichte
none
Andere Medikamente
Amoxicillin started on 6/17 for ear infection - completed course day prior to vaccine
Allergien
None known
Vorherige Impfungen
-

VAERS 2697953

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
DC
Alter
-
Geschlecht
U
Eingang
18.10.2023
Impfdatum
13.10.2023
Beginn
13.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; HCP called to report inadvertent administration of expired MMR-II to a patient. MMR-II expired on 10/07/2023 and was given to the patient on 10/13/2023.; This spontaneous report was received from a nurse referring to patient of unknown age and gender. The patient's medical history, concurrent condition, and concomitant medications were not reported. On 13-OCT-2023, the patient was inadvertently vaccinated with expired measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live recombinant human albumin ([rHA]) (M-M-R II) injection (lot# U031359, expiry date: 07-OCT-2023; dose, route of administration, and anatomical location not reported) as prophylaxis (expired product administered). There was no additional adverse event (AE) (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2696884

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
17.10.2023
Impfdatum
11.10.2023
Beginn
07.10.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE/PQC reported.; Nurse calling to report adverse event regarding an administration of an expired dose of MMR II. Nurse stated that the MMR II dose had a labeled lot / expiry of U031359 10/7/2023, and the dose was inadvertently administered on 10/11/2023. Nurse conf; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 11-OCT-2023, the patient started therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, 0.5 ml / two dose series, lot #U031359, expiration date: 07-OCT-2023, administered for prophylaxis (strength, and route of administration were not provided). On 07-OCT-2023, Nurse called to report adverse event regarding an administration of an expired dose of MMR II. Nurse stated that the MMR II dose had a labeled lot / expiry of U031359 07-OCT-2023, and the dose was inadvertently administered on 11-OCT-2023. Nurse confirmed this was the patient's first dose in the series, and that the patient has not reported any medical concerns or symptoms due to being administered the expired dose of MMR II. No additional information provided regarding this adverse event. Nurse consents to correspondence regarding this adverse event. Case number provided. No additional AE/PQC reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2695210

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
MA
Alter
-
Geschlecht
U
Eingang
12.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No adverse effects reported. No additional AE.; HBP calling to report post expiry dose of MMR II. No adverse effects reported. No additional AE. No PQC. LOT U031359 Exp. 10/7/2023; This spontaneous report was received from offiece manager and refers to a 12-month-old. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 10-OCT-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, single dose, lot #U031359, expiration date: 07-OCT-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2667606

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
NH
Alter
-
Geschlecht
U
Eingang
08.08.2023
Impfdatum
-
Beginn
26.07.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; Improperly Stored / Administered; This spontaneous report was received from a nurse (other health professional) referred to a patient of unknown age and gender via phone call. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 26-JUL-2023, the patient was administered with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, 0.5 milliliter once, lot #U031359, expiration date: 07-OCT-2023, administered for prophylaxis (strength, and route of administration were not provided). The administered vaccine had twice temperature excursion (improper storage of product in use). No symptomatic adverse event was reported. Caller declined to provide full patient demographics and could only provide initials of patient. No additional details at this time. No additional AE/PQC reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2663793

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
NH
Alter
-
Geschlecht
U
Eingang
01.08.2023
Impfdatum
26.07.2023
Beginn
26.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Confirmed that no symptomatic adverse event was reported / No additional AE; Inbound call from nurse calling to report TE for MMR-II. Caller states product was administered to patient on 7/26/2023; This spontaneous report has been received from a registered nurse, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported. On 26-JUL-2023, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, rHA (recombinant Human albumin) (M-M-R II) injection, 0.5 milliliter/once (lot number U031359 was verified to be valid, expiration date reported and confirmed as 07-OCT-2023), administered as prophylaxis (route of administration and anatomical location were not provided). The vaccine administered had had a temperature excursion of 9.6 degree Celsius (C), during a time frame of 16 minutes, and had a previous temperature excursion during 14 minutes with high of 8.6C. (Product storage error). No symptomatic adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2610264

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
FL
Alter
31,0
Geschlecht
M
Eingang
05.04.2023
Impfdatum
12.02.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation error

Symptomtext

patient received a dose of MMR II that was reconstituted with "sodium chloride or sterile water" instead of the Merck supplied diluent.; No adverse effects were reported; This spontaneous report has been received from pharmacist referring a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, (recombinant human albumin (rHA)(M-M-R II) subcutaneous injection, lot number U031359 that had been verified to be a valid number with expiration date 07-OCT-2023, administered for prophylaxis (strength, specific dosage, vaccination scheme, route of administration and anatomical site of application were not provided) that was reconstituted with an unspecified brand of "sodium chloride or sterile water" instead of the Merck supplied diluent (product preparation error). No adverse effects were reported This case was classified as non-valid due to lack of patient identifiers. Follow-up information has been received from the pharmacist on 30-MAR-2023 referring an approximately 31-year-old male patient. On 12-FEB-2023, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live, (recombinant human albumin (rHA)(M-M-R II) subcutaneous injection, lot number U031359 that had been verified to be a valid number with expiration date 07-OCT-2023 (also reported as 6024220), administered subcutaneously in a left limb (strength, specific dosage, and vaccination scheme, were not provided). The patient was contacted several times and no answer was received. This case was considered valid as patient identifiers were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
SODIUM CHLORIDE
Allergien
-
Vorherige Impfungen
-

VAERS 2595506

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
AR
Alter
4,0
Geschlecht
F
Eingang
13.03.2023
Impfdatum
03.01.2023
Beginn
03.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Vaccination error

Symptomtext

On January 3rd, 2023, patient was at clinic for immunizations. She was in need of her 5th dose of DTAP, 5th dose of polio, and 4th dose of hep B, 2nd dose of MMR and 2nd dose of Varicella. In order to administer less needle sticks to the child, the pediarix combination vaccine was administered. Because Pediarix is only approved for doses 1, 2, and 3 of the primary DTaP series, this was a vaccination error. The minimum recommended intervals were met for each component of the vaccine, therefore, the doses were considered valid. No adverse event occurred as a result of this vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2583213

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
OH
Alter
-
Geschlecht
U
Eingang
17.02.2023
Impfdatum
27.01.2023
Beginn
27.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional information provided. No additional AE reported. No PQC.; HCP reporting one dose of VARIVAX and one dose of MMR II were administered after a temperature excursion.; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided. On 27-JAN-2023, the patient was vaccinated with improperly stored doses of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection at a dose 0.5 milliliter (ml) as prophylaxis (lot number W011625 has been verified to be valid; expiration date reported and established as 06-APR-2024) (strength, route of administration, and anatomical location were not provided), and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant Human albumin) (M-M-R II) subcutaneous injection at a dose of 0.5 ml as prophylaxis (lot number U031359 has been verified to be valid; expiration date reported and established as 07-OCT-2023) (strength, route of administration and anatomical location were not provided). The administered dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) was stored at a temperature of 30.4 degrees Fahrenheit (F), during a time frame of 1 hour and 15 minutes, and the administered dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant Human albumin) (M-M-R II) was stored at a temperature of 53.1 degrees F, during a time frame of 1 hour and 15 minutes. There was not a previous temperature excursion reported. There was no adverse effect reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2365782

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U031359

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
12.07.2022
Impfdatum
-
Beginn
24.06.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product No adverse event Occupational exposure to product

Symptomtext

No additional AEs were reported; assistant got some of MMR II vaccine splashed into the eyes while handling a syringe which contained reconstituted MMR II; assistant got some of MMR II vaccine splashed into the eyes while handling a syringe which contained reconstituted MMR II; This spontaneous report was received from an office manager and refers to a medical assistant of unknown age and gender. On 24-JUN-2022, the medical assisstant got some of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) recombinant human albumin (rHA) lot #U031359, expiration date: 07-OCT-2023 splashed into the eyes while handling a syringe (occupational exposure to product, accidental exposure to product). No adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-